Geovax Labs (Geovax Labs) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Geovax Labs ROE % Adjusted to Book Value?

Geovax Labs's ROE % for the quarter that ended in Mar. 2024 was -804.54%. Geovax Labs's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Geovax Labs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Geovax Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Geovax Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geovax Labs ROE % Adjusted to Book Value Chart

Geovax Labs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Geovax Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Geovax Labs's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Geovax Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Geovax Labs's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Geovax Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Geovax Labs's ROE % Adjusted to Book Value falls into.

Geovax Labs ROE % Adjusted to Book Value Calculation

Geovax Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-160.47%	/	N/A
	=	N/A

Geovax Labs's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-804.54%	/	N/A
	=	N/A

Geovax Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Geovax Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Geovax Labs (Geovax Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geovax Labs Inc (NAS:GOVXW) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GOVX:USA E8L:Germany

Address

1900 Lake Park Drive, Suite 380, Smyrna, GA, USA, 30080

Website

https://www.geovax.com

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.